Clinical Trial Update: Safety Study Comparing Phenylephrine HCL Extended Release Tablets 30 mg and Placebo (Study CL2007-07)(P07529)(COMPLETED) [Phase 3]

View source ↗

Summary

A Phase 3 safety study comparing Phenylephrine HCl Extended Release 30 mg tablets to placebo has completed, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Phenylephrine HCl Extended Release Tablets 30 mg (phenylephrine hydrochloride extended-release tablet 30 mg)

Snippet

Sponsor: Bayer | Conditions: Blood Pressure, Human Experimentation | Phase 3 | Status: COMPLETED | Results posted: 2010-07-05